Swahili Swahili
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

podcasts

Sehemu ya 2: Kinga iliyokuwepo dhidi ya Serboi ya AAV na Inamaanisha Nini kwa Majaribio ya Kliniki ya Hemophilia Gene

Iliyotolewa na Steven W. Bomba, MD na Nigel Key, MB, ChB. FRCP

Adeno-Associated Virus (AAV) Uhamisho wa Gene wa kati: Kwanini Huu ni Mkakati wa Kutabiri kwa Tiba ya Hemophilia Gene?

Iliyotolewa na Steven W. Bomba, MD na Nigel Key, MB, ChB. FRCP

Ufuatiliaji wa Muda mrefu Kufuatia Tiba ya Hemophilia ya Gene

Iliyotolewa na Steven W. Bomba, MD na Nigel Key, MB, ChB. FRCP

Mambo muhimu kutoka kwa Warsha ya 15 ya NHF juu ya Teknolojia za riwaya na Uhamisho wa Gene kwa Hemophilia

Iliyowasilishwa na David Lillicrap, MD na Glenn F. Peirce, MD, PhD

Kikundi Kazi cha Tiba ya Jeni cha EAHAD

Iliyotolewa na Wolfgang Miesbach, MD

Historia ya EAHAD na Bunge lijalo

Iliyotolewa na Aislin Ryan, Mkurugenzi Mtendaji wa EAHAD

Tiba ya Jeni ya ISTH kwa Mpango wa Hemophilia na Wajibu wa EAHAD

Iliyowasilishwa na Flora Peyvandi, MD, PhD

Rejea Juu
Image

Please enable the javascript to submit this form

kuhusu

Inafadhiliwa na ruzuku za elimu kutoka Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, na uniQure, Inc.

SSL muhimu